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Abstract
Background: Headache is one of the most common reason for medical consultation to emergency department
(ED). The inappropriate use of ED for non-emergency conditions is a problem in terms of overcrowding of emergency
facilities, unnecessary testing and treatment, increased medical costs, burden on medical service providers and weaker
relationships between patient and primary care provider. The aim of this study was to analyze the different stages of
ED management of headache to identify those deficiencies that can be overcome by a fast referral to a headache
clinic.
Methods: The study is a retrospective analysis of the electronic medical records of patients discharged from an
academic ED between January 1, 2015 and December 31, 2018 and referred to the tertiary level headache centre
of the same hospital. We analyzed all aspects related to the permanence in ED and also assessed whether there
was a match between the diagnosis made in ED and ours.
Results: Among our sample of 244 patients, 76.2% were admitted as “green tag”, 75% underwent a head computed
tomography, 19.3% received a neurological consultation, 43% did not receive any pharmacological treatment and 62.7% still
had headache at discharge. The length of stay in ED was associated with reporting the first aura ever (p = 0.014) and
whether patients received consultations (p < 0.001). The concordance analysis shown a significant moderate agreement only
for the diagnosis of migraine and only between triage and headache centre.
Conclusions: Most patients who went to ED complaining of headache received the same treatment regardless of their
diagnosis and in many cases the headache had not yet resolved at the time of discharge. Given the many shortcomings in
headache management in ED, rapid referral to the headache centre is of paramount importance to help the patient achieve
a definiteve diagnosis and appropriate treatment.
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Introduction
Headache is one of the most common symptoms and an
important reason for medical consultation and presenta-
tion to emergency departments (EDs). In fact, of all pa-
tients visiting EDs, up to 4.5% report that non-traumatic
headache is their main complaint [1]. The third edition
of the International Classification of Headache Disorders
(ICHD-III) distinguishes between secondary headaches,
where headache is a symptom, and primary headaches,
which include migraine (with or without aura), tension-
type headache and the group of trigeminal autonomic
cephalalgias (TACs) for which cluster headache counts
for the majority [2]. Migraine alone is the world’s second
leading cause of years of life lived with disability [3] and
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chronic migraine (CM) patients, who have ≥15 headache
days per month, are more likely to have a higher disabil-
ity, lower quality of life and greater use of healthcare re-
sources than patients with episodic migraine (EM) [4, 5].
In the ED, as in the general population, primary headache
disorders are much more common than secondary disorders
and it can be challenging for ED doctors to distinguish the
few patients with potentially life-threatening headaches from
the vast majority with benign headaches [6]. Primary head-
ache is diagnosed in 58–81.2% of ED patients with headache
and, for the specific diagnosis of primary headache, migraine
is the main condition, representing 17–64% of cases [7–11].
While most headaches have a benign etiology and are self-
limiting, up to 5% have a serious and life-threatening cause
(e.g., subarachnoid hemorrhage) that requires immediate
medical attention [12, 13].
Inappropriate use of ED for non-emergency conditions is a
problem in terms of overcrowding of emergency facilities,
unnecessary testing and treatment, increased medical costs,
burden on medical service providers and weaker relation-
ships between patient and primary care provider. Studies
evaluating this phenomenon have found that the inability to
take time off from school or work during the day and the
ease of use of emergency care without the need for an ap-
pointment are cited as a reason for their consultation by a
significant percentage of patients, suggesting that inappropri-
ate use of ED could be a matter of personal convenience [14,
15]. An observational study investigated the factors associ-
ated with ED visits for headache and found that the most
common reason for visiting ED was a perceived emergency
condition or referral by a physician (33.3%) [16]. The other
most commonly cited reasons were the timeliness of the
treatment, either because the doctor’s office was closed (20%)
or because patients could not get an appointment early
enough (11%), or because they did not have a doctor or no
other place to go (9%) [17]. Studies conducted in other coun-
tries suggest that primary headaches are under- or misdiag-
nosed and, as a result, patients are often undertreated or
receiving inadequate care when consulting an ED [8, 17, 18].
In our hospital there is close collaboration with ED
and all patients suffering from headache after discharge
can be referred to our clinic and visited within 36 h.
Given the lack of Italian studies on patients presenting
with headache to ED, we analyzed the different stages of
headache management to identify the deficiencies that can
be overcome with a quick referral to a headache clinic. In
particular, we evaluated the demographic and clinical fea-
tures of these patients, the frequency and accuracy of head-
ache diagnosis, the treatment they received and their follow-
up in our headache center.
Methods
The study is a retrospective analysis of the electronic
medical records (EMRs) of patients who presented to
the academic ED of Azienda Ospedaliera Sant’Andrea,
between January 1, 2015 and December 31, 2018, with
a chief compliant of headache and who, after discharge,
were referred to the Regional Referral Headache
Centre, Department of Clinical and Molecular Medi-
cine, Faculty of Medicine and Psychology, Sapienza
University of Rome.
Data collection
The data analyzed included basic demographic informa-
tion, presentation time, priority assessment and diagno-
sis of admission by the hospital triage nurse, door-to-
doctor time and the length of stay in ED, life parameters,
diagnostic investigations, specialist consultations, treat-
ment administration and discharge diagnosis. We also
assessed the time elapsed between discharge from the
ED and the first visit to our headache center and
whether there was a match between the diagnosis of dis-
charge from the ED and ours.
For priority admission, our ED uses an advanced triage
system that provides a color-coding scheme that uses
white, green, yellow and red tags to define conditions at
an increasing level of severity:
 white tags - (dismiss) are given to those with minor
injuries for whom a doctor’s care is not required;
 green tags - (wait) are reserved for the “walking
wounded” who will need medical care at some point,
after more critical injuries have been treated;
 yellow tags - (observation) for those who require
observation (and possible later re-triage). Their con-
dition is stable for the moment and, they are not in
immediate danger of death. These victims will still
need hospital care and would be treated immediately
under normal circumstances;
 red tags - (immediate) are used to label those who
cannot survive without immediate treatment but
who have a chance of survival.
For vital signs analysis, elevated blood pressure (BP)
was defined as follows: systolic BP (SBP) ≥140 mmHg or
diastolic BP (DBP) ≥90mmHg [19].
The diagnosis in our headache centre was made on
the basis of the beta version or the final version of the
ICHD-III depending on the year in which the visit was
carried out [2, 20].
Statistical analyses
A descriptive analysis of the sample characteristics was
carried out. The categorical data were summarized by
numbers and percentages, the continuous data by mean
and standard deviation. The association between total
time in ED and follow-up at the headache centre was
evaluated by Mann-Whitney tests. The concordance
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between primary headaches diagnosis was assessed using
the Cohen Kappa coefficient (κ). The significance level
was set at 0.05 (always corrected if necessary). All ana-
lyses were performed using SAS 9.4 (SAS Institute Inc.,
Cary, NC, USA).
Results
Demographics and clinical characteristics of the study
population
Demographic and clinical characteristics of patients
treated in ED are summarized in Table 1. The sample
analyzed consisted of 244 patients, 192 (78.7%) women
and 52 (21.3%) men, aged between 14 and 89 years and
an average of 40.7 years. After evaluating the general
conditions, the triage nurses coded one patient (0.4%) as
a white tag, 186 (76.2%) as a green tag, 56 (23.0%) as a
yellow tag and one patient (0.4%) as a red tag. Medical
history was negative for any conditions in 157 (64.3%)
patients. Among the various pathologies, the most fre-
quent were hypertension (in 11.1% of patients), psychi-
atric disorders (in 8.6% of patients) and thyroid diseases
(in 7.0% of patients). Patients presented to ED after an
average of 1.9 days after the onset of the headache for
which they needed assistance. The appearance of a mi-
graine aura was the main reason for consulting for ED
for 40 (16.4) patients and for 16 (40%) of them it was
the first aura of their lives. Mean values of vital signs for
the whole sample of patients were in the normal range:
systolic pressure was 130 mmHg (range: 100–190), dia-
stolic pressure was 77 mmHg (range: 50–111), heart rate
was 78 bpm (range: 39–116), temperature was 36.6 °C
(range: 35.9–38) and oxygen saturation was 98% (range:
94–100).
Diagnosis of headache in the emergency department
Table 2 summarized the changes in diagnoses in relation
to the setting of the clinical evaluation. We found eleven
different admission diagnoses assessed by the triage nurse.
The three most common diagnoses were headache
(63.6%), migraine without aura (9.0%) and ophthalmic
headache (6.6%). ED physicians used fewer diagnoses
(four) and the most frequent was headache (52.5%).
Headache investigations received in the emergency
department
Most patients performed complementary examinations
for diagnosis (Table 3). The most common investigation
was head computed tomography (CT) required for 183
(75%) patients. One patient with a known diagnosis of
migraine refused to have a CT scan. Of the 182 CT
scans performed 171 (94%) were negative and 11 (6%)
had findings that were all considered incidental: sphen-
oid and maxillary sinus mucosal thickening (3), mega
cisterna magna (2), sinusitis (1), chronic ischemic
leukoencephalopathy (1), < 5 mm engagement of cerebel-
lar tonsils into the foramen magnum (1), subcutaneous
sebaceous cyst (1), aneurysm of basilar artery (1) and oc-
cipital bone exostoses (1). The second most common in-
vestigation was electrocardiogram (ECG) performed in
Table 1 Demographic and clinical characteristics of patients
treated in the emergency department
Demographics
age (years) (SD) 40.7 (16.3)
sex (female) 192 (78.7)
Medical history
negative 157 (64.3)
hypertension 27 (11.1)
psychiatric disorders 21 (8.6)
thyroid disorders 17 (7.0)
hematologic disorders 10 (4.1)
dyslipidemia 9 (3.7)
DM type 2 8 (3.3)
cerebrovascular diseases 7 (2.9)
COPD/asthma 4 (1.6)
ischemic heart disease 3 (1.2)
solid tumor 3 (1.2)
Time of ED presentation
08:00–15:59 147 (60.3)
16:00–23:59 79 (32.4)
00:00–07:59 18 (7.4)
Headache onset
days bedore ED visit 1.9 (5.7)
Triage codes
white 1 (0.4)
green 186 (76.2)
yellow 56 (23.0)
red 1 (0.4)
Vital signs
systolic BP (mmHg) 130 (16.9)
diastolic BP (mmHg) 77 (10.6)
heart rate (bpm) 78,910.60
temperature (°C) 36.6
oxygen saturation (%) 98 (1.4)
Aura
reason to access ED 40 (16.4)
first aura in their life 16 of 40 (40.0)
ED times in min, mean (SD)
door-to-doctor time 139 (118.4)
time of care 241 (269.8)
ED length of stay 381 (307.7)
DM diabetes mellitus, ED emergency department, SD standard deviation
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31 (12.7%) patients without any correlation with vital
signs. All ECGs were reported as non-pathological. Fi-
nally, 16 (6.6%) patients underwent other investigations
besides head CT and ECG: supra-aortic trunk echo-
doppler (8), sinus CT scan (3), brain magnetic resonance
imaging (MRI) (2), cervical X-rays (2) and electro-
encephalogram (1).
Specialist consultations received in the emergency
department
Most patients were managed by ED physicians without
the need for specialist consultation (Table 3). Of a total
population of 244 patients, 47 (19.3%) were examined by
a neurologist, 7 (2.9%) by an ophthalmologist, 5 (2.0%)
by an otolaryngologist, 5 (2.0%) by a psychiatrist, 2
(0.8%) by a cardiologist and 2 (0.8%) by a neurosurgeon.
Headache treatment received in the emergency
department
Pharmacological treatments administered in ED are
summarized in Table 3. NSAIDs and weak opioids were
the most commonly prescribed pharmacological agents,
being administered in 44.3% and 17.6%. of patients re-
spectively. None of the 244 patients received a triptan.
Treatment of associated symptoms included antiemetics
and anxiolytics, administered to 12.7% and 4.9% of
patients respectively. Proton pump inhibitors were ad-
ministered to 10.2% of patients. Approximately 43% of
patients received no pharmacological treatment, while
among patients treated 25% received monotherapy, and
18.4% and 9.8% received a combination of two or three
pharmacological agents, respectively.
Triage and stay information in the emergency
department
Information on ED stay of the 244 patients is summa-
rized in Table 4. The median door-to-doctor time was
139 (range: 3–881), the median time of care (from first
contact with ED to discharge) was 241 min (range: 1–
1404) and the mean time of stay (from arrival in ED to
discharge) was 381 min (range: 20–2212). There was no
significant correlation between the length of stay in ED
and a number of factors (arrival time in ED, triage cod-
ing, blood pressure, head CT scan, ECG, other investiga-
tions and treatment administration). In contrast, the
length of time spent in ED was significantly associated
with some factors. In particular, having received neuro-
logical consultation (p < 0.001) or other specialist visits
(p = 0.001) was associated with a longer stay in ED while
the complaint of the first aura ever (p = 0.014) was asso-
ciated with a shorter stay in ED.
Table 2 Changes in diagnoses in relation to the clinical evaluation setting
DIAGNOSIS TRIAGE
nurse
ED doctor Headache
centre
Concordance TRIAGE - headache
centre
(244 patients) (244 patients) (240 patients) (κ; p - value)
Headache 155 (63.6) 128 (52.5) –
Migraine without aura 22 (9.0) 82 (33.6) 140 (57.4) 0.581; p < 0.001
Migraine with aura (ophthalmic headache) 16 (6.6) – 34 (13.9) 0.032; p = 0.586
Tension-type headache – – 32 (13.1) –
Chronic migraine – – 35 (14.3) –
Medication overuse headache – – 31 (12.7) –
Cluster hedache 2 (0.8) 2 (0.8) 7 (2.9) −0.013; p = 0.001
Other TACs – – 1 (0.4) –
Trigeminal neuralgia 8 (3.3) – 3 (1.2) –
Headache attributed to trauma 5 (2.1) 32 (13.1) 8 (3.3) –
Sinusitis – – 2 (0.8) –
Headache attributed to cranial and/or cervical vascular
disorder
16 (6.6) – 6 (2.5) –
Headache and arterial hypertension 10 (4.1) – 5 (2.0) –
Headache and systemic infection 6 (2.5) – 1 (0.4) –
Headache and anxiety disorder 3 (1.2) – – –
Cervicogenic headache 1 (0.4) – – –
TACs trigeminal autonomic cephalalgias
Triage nurses used the definition “ophthalmic headache” to indicate the diagnosis of “migraine with aura”
The concordance between primary headaches diagnosis was assessed using the Cohen Kappa coefficient (κ). The significance level was set at 0.05
There was not agreement between diagnoses made by ED physicians and headache centre
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Discharge
Discharge information are summarized in Table 5. At the
time of discharge from ED the headache had not disap-
peared in 62.7% of the 244 patients and 43.9% of the pa-
tients had been discharged without a prescription. The
most commonly prescribed medications for the treatment
of headache were NSAIDs and paracetamol, administered
to 33.2% and 11.1% of patients respectively, while triptans
were prescribed to only 1.6%. Monotherapy was pre-
scribed more frequently than combination therapy with
two agents (44.7%% vs 10.2%). Only 5.8% of patients were
prescribed prophylactic treatment upon discharge. The
most common post-discharge investigation was cerebral
MRI, which was prescribed to 4.1% of patients, while in
92.6% of patients no further investigation was required.
Follow-up in the headache Centre
Information on follow-up visit to the headache centre is
summarized in Table 6. The average follow-up time at
Table 3 Interventions in the emergency department
Investigations
head CT 183 (75.0)
ECG 31 (12.7)
other 16 (6.6)
Specialist consultations
neurologist 47 (19.3)
ophthalmologist 7 (2.9)
otolaryngologist 5 (2.0)
psychiatrist 5 (2.0)
cardiologist 2 (0.8)
neurosurgeon 2 (0.8)
Treatment administered
none 105 (43.0)
NSAIDs 108 (44.3)
weak opioids 43 (17.6)
antiemetics 31 (12.7)
PPIs 25 (10.2)
paracetamol 20 (8.2)
corticosteroids 16 (6.6)
anxiolitics 12 (4.9)
antibiotics 2 (0.8)
Classes of drugs (in ED)
one 61 (25.0)
two 45 (18.4)
three 24 (9.8)
four 7 (2.9)
five 2 (0.8)
CT computed tomography, ECG electrocardiogram, ED emergency department,
NSAIDs non-steroidal anti-inflammatory drugs, PPIs proton pump inhibitors
Table 4 Factors that influence the length of stay in the
emergency department
LENGTH OF STAY IN ENERGENCY DEPARTMENT
mean min max SD p-value
Time of arrival
08:00–15:59 381 20 2212 327 NS
16:00–23:59 393 37 1540 277
00:00–07:59 321 72 740 211
Triage
white 320 320 320 . NS
green 380 20 1540 282
yellow 387 37 2212 373
red 202 202 202 .
Aura
no 368 20 2212 291 NS
yes 446 37 1412 360
First aura
no 527 133 1412 376 0.014
yes 325 37 1386 306
SBP≥ 140mmHg
no 383 20 2212 304 NS
yes 373 37 1529 306
DBP≥ 90mmHg
no 389 20 2212 312 NS
yes 271 92 479 114
HEAD CT
no 349 20 1540 270 NS
yes 391 37 2212 314
ECG
no 359 20 1540 260 NS
yes 531 37 2212 492
Other investifgations
no 372 20 2212 294 NS
yes 510 37 1386 413
Neurological consultation
no 333 20 2212 252 < 0.001
yes 580 37 1533 408
Other consultations
no 359 20 2212 279 0.001
yes 625 115 1533 447
Treatment
no 385 41 1529 303 NS
yes 377 20 2212 305
CT computed tomography, DBP diastolic blood pressure; NS not significant,
SBP systolic blood pressure, SD standard deviation
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our headache centre was 8.9 days (range: 1–30) after ED
discharge and 4 (1.6%) patients did not show up for the
appointment. Considering the entire sample of 244 pa-
tients, 97.5% were new patients and 2.5% were already
followed up at our headache clinic. All 240 patients who
attended the follow-up appointment at our clinic were
diagnosed with headache according to the ICHD [2, 20].
Most patients (66.7%) were already aware of the diagno-
sis. A primary form of headache was diagnosed in 90%
of patients, while a secondary headache was diagnosed
in 10%. The three most common primary headache diag-
noses were migraine without aura (53.3%), CM (14.6%)
and migraine without aura (14.2%). The three most
common diagnoses of secondary headache were medica-
tion overuse headache (MOH) (12.7%), headache attrib-
uted to trauma (3.3%) and headache attributed to cranial
and/or cervical vascular disorder (2.5%). A double diag-
nosis was given to 24.6% and a triple diagnosis to 1.2%
of the patients. The most frequent combinations of two
diagnoses were CM and MOH (11.7%) followed by mi-
graine with aura and migraine without aura (9.6%). The
most frequent combination of three diagnoses was CM,
MOH and migraine with aura (0.8%) followed by CM,
MOH and headache attributed to cranial and/or cervical
vascular disorder (0.4%). The average age at the onset of
their headache was 25 years (range: 6–89) and 45% had a
family history of migraine. Patients were managed ac-
cording to their headache diagnosis. All patients with a
new migraine diagnosis were prescribed specific acute
treatment for migraine (e.g., triptans), where it was not
contraindicated. Those patients with a known diagnosis
of migraine who had already experienced problems of ef-
ficacy and/or tolerability with the triptan they had
already used, were prescribed another molecule belong-
ing to the triptan class and/or analgesic combination
(e.g., paracetamol plus caffeine or codeine). Both patients
with migraine and tension-type headache with > 4 at-
tacks per month received oral prevention treatments ac-
cording to international guidelines [21]. With regard to
CM prevention, 24 (68.6%) of 35 patients with this diag-
nosis were prescribed quarterly injections of onabotuli-
numtoxinA [22, 23] and 26 (83.9%) of 31 patients with
MOH started an in-patient withdrawal and rehabilitation
protocol [24].
Discussion
We conducted a retrospective study on a consecutive
sample of 244 patients observed in our tertiary headache
centre after direct referral from the ED of our hospital,
where they presented with a chief compliant of head-
ache. Our aim was to analyzed the different stages of ED
management of patients with headache to identify those
deficiencies that can be overcome by a rapid referral to a
headache clinic.
The first step of this journey is the need to make the
correct diagnosis. The assessment of headache patients
in the ED environment differs significantly from the as-
sessment of headache patients in the clinic. Management
of headache in an acute setting should focus on the ex-
clusion of serious secondary causes, correct diagnosis,
symptoms management and possibly the establishment
of a continuing care plan [25]. The sense of urgency to
exclude secondary and often life-threatening causes of
headache, also due to time constraints due to the need
Table 5 Discharge from the emergency department
Headache at discharge
no 153 (62.7)
yes 91 (37.3)
Drugs prescription
none 107 (43.9)
NSAIDs 81 (33.2)
paracetamol 27 (11.1)
weak opioids 19 (7.8)
prevention 14 (5.8)
corticosteroids 5 (2.0)
triptans 4 (1.6)
anxiolitics 2 (0.8)
antiemetics 1 (0.4)
antibiotics 1 (0.4)
Classes of drugs (at discharge)
one 109 (44.7)
two 25 (10.2)
three 3 (1.2)
Post-discharge investigations
brain MRI + angio-MRI 12 (4.8)
EEG 2 (0.8)
psychiatric visit 2 (0.8)
Holter blood pressure 2 (0.8)
EEG electroencephalogram, MRI magnetic resonance imaging, NSAIDs non-
steroidal anti-inflammatory drugs
Table 6 Follow-up in the headache centre
Age at the onset (years) (SD) 25 (18.1)
New patient to our headache clinic 238 (97.5)
Days since discarge 8.9 (7.2)
Familiarity for headache (yes) 108 (45.0)
Aware of their diagnosis (yes) 160 (66.7)
Headache days per month 12.6 (9.5)
OnabotulinumtoxinA for CM 24 of 35 (68.6)
Rehabilitation for MOH 26 0f 31 (83.9)
CM chronic migraine, MOH medication overuse headache, SD
standard deviation
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for efficient patient management, may lead ED physi-
cians to interrupt the diagnostic process on the differen-
tial diagnosis between primary and secondary headache.
A Canadian study to assess the diagnostic accuracy of
neurological complaints in ED found that in 35.7% of
cases the initial ED diagnosis was not consistent with
the final diagnosis made by a neurologist; among the
most common misdiagnosed problems were primary
headaches [26]. There was a high rate of discrepancy be-
tween the diagnosis made in our headache centre and
the diagnosis made in ED. This discrepancy may have
several reasons. ED physicians may be more interested
in excluding serious causes of headache than in distin-
guishing different primary headaches or they are simply
not familiar with the diagnostic criteria of ICHD. How-
ever, even if they were aware of the diagnostic criteria,
ED physicians may not have adopted them because they
intended to use the same treatment regardless of the
diagnosis of primary headache. In addition, there is a
possibility that ED physicians may simply accept the
diagnosis of a triage nurse or not change the diagnosis
already in the system. However, the interesting finding
was that triage nurses used eleven different diagnosis,
most of which simply describing a condition associated
with headache, while ED physicians used only four diag-
nostic categories (Table 2). This finding provides further
evidence of what ED physicians may consider to be their
primary task, namely to rule out severe secondary head-
ache rather than make a definitive diagnosis. The ana-
lyses of concordance among the three different
diagnoses (triage, ED physician and headache centre)
showed a significant moderate concordance only for the
diagnosis of migraine and only between triage and head-
ache centre. This latter finding is perhaps due to the fact
that most patients (66.7%) were already aware of their
headache diagnosis and the triage nurse took the infor-
mation obtained from the patients and used it to com-
pile the triage diagnosis.
The second step of the journey are the diagnostic in-
vestigations that may be necessary to confirm the diag-
nostic suspect and establish consistent treatment. Head
CT scans are commonly used to assess headache due to
their rapid accessibility and diagnostic accuracy, but un-
necessary head CT scans lead to a longer ED stay [27],
exposure to radiations [28] and increased medical costs
[29]. The use of CT scans for non-traumatic headache in
the United States EDs has doubled in the last 20 years
[30]. Up to 31% of patients who had headache under-
went imaging [30] and head CT scans accounted for al-
most 50% all CT scans in the United States EDs [31].
However, almost 95% of the CT scans carried out in the
United States EDs between 1992 and 2001 showed no
pathological results [12]. We found that 75% of patients
who attended our ED with a major compliant of
headache had a CT scan, which was negative in 93.4% of
cases, while in the other cases the results were all consid-
ered accidental and not life-threatening (Table 3). How-
ever, this large use of CT scan in ED requires serious
reflection. In fact, a recent study found that a 9.6% de-
crease in the use of head CT scans for patients presenting
to ED with a major headache complaint was not followed
by an increase in deaths or missed diagnoses [32] This
data provides convincing evidence that there is a possibil-
ity of safely decreasing CT scans for ED patients. Con-
versely, in support of CT use, another study found that
patients who underwent a head CT scan during an initial
ED visit were about half as likely to return to ED within
30 days than those who had not had CT [33]. Head
imaging has been shown to have a positive influence on
patients’ fear and anxiety levels [34] and, by reassuring pa-
tients, CT scan prevent them from returning to ED. How-
ever, we can hypothesize that a rapid referral to a
headache unit may have, at least in some patients, a simi-
lar reassuring effect, but avoiding the impact of the CT
scan on the patient and the healthcare system.
The third step is the request for specialist consulta-
tions to add experience to the work of ED physicians. In
our ED at least one neurologist is available 24 h a day, 7
days a week, both for the first line assessment if the pre-
hospital assessment suggests a neurological condition,
and for the second line, according to the judgement of a
ED physician who is not a neurologist when the patient
arrives. However, less than a fifth (19.3%) of patients re-
ceived a neurological consultation (Table 3). This rate
was lower than in another study in French EDs, where
one third of patients received a consultation with a neur-
ologist [8]. The authors hypothesized that this may have
been due to the fact that patients were experiencing an
unusually severe attack or because a differential diagno-
sis was considered necessary for patients who had re-
ported a first episode of headache. We can speculate
that there may be a number of reasons for the fewer
consultations in our study, including the doctor’s cer-
tainty that a secondary headache is ruled out and know-
ledge of the possibility of a rapid referral to our
headache clinic. Further consultations were requested
for 8.2% of patients and the three most frequently
consulted specialists were ophthalmologists (for aura),
otolaryngologists (for sinusitis) and psychiatrists (for co-
morbid conditions). However, receiving specialist con-
sultations, both neurological and other, was the only
factor that was significantly associated with a longer stay
in ED (Table 4). On the contrary, the complaint of the
first aura in life was associated with a shorter stay in ED.
It is possible that when faced a patient who reported
having previously had other episodes of aura, the ED
doctor was reassured on the benignity of the symptom,
while in the case of the first aura the doctor was more
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cautious and felt the urgency to handle the case. This
fact could also indicate an inadequate knowledge of the
diagnostic criteria of primary headaches in general, and
specifically the clinical spectrum of migraine.
The fourth and fundamental step in the management of
headaches in ED is the pharmacological treatment. Patients
with migraine or other headaches have the third highest self-
reported pain score of all patients presenting to ED with a
painful condition [35]. Consistently, the American Migraine
Prevalence and Prevention (AMPP) study found that unbear-
able pain was the most common reason for the use of ED
for migraine [36]. Patients attending ED with a headache pat-
tern similar to previous migraine attacks generally do not re-
quire, or do not want, diagnostic tests, but expect rapid and
effective management of their headache and any misdiag-
nosis can lead to generalized pain treatment rather than of
specific treatment for migraine [18]. More than 20 different
drugs and drug combinations are used to treat migraine in
ED, including migraine-specific drugs (e.g., sumatriptan and
dihydroergotamine), dopamine antagonists (e.g., metoclopra-
mide, chlorpromazine and prochlorperazine), NSAIDs,
opioids, corticosteroids, and anti-histamines (e.g., diphen-
hydramine and promethazine) [37]. In our ED, the most
commonly prescribed pharmacological agents were NSAIDs
and weak opioids, administered to 44.3% and 17.6%. of pa-
tients respectively, followed by paracetamol, which was ad-
ministered to 8.2% of patients (Table 3). Treatment of the
associated symptoms included antiemetics and anxiolytics,
administered to 12.7% and 4.9% of patients respectively. An-
other study conducted in Europe showed opposite use of
NSAIDs (42.9%) and non-opioid analgesics (61.2%) and
lower use of antiemetics (8%) and anxiolytics (3%) [8]. In the
above mentioned study, approximately 9% of patients did
not receive any pharmacological treatment and triptans were
not administered frequently (11.2%) [8]. In our sample, about
43% of patients did not receive any medications and no trip-
tans (or ergotamines) were administered. However, the
underutilization of headache medications in ED is not lim-
ited to European countries. A survey conducted in a univer-
sity hospital ED in the United States found an equally high
percentage of patients (38%) who received neither drugs nor
intravenous fluids [18].
The role of the ED physician is not only to rule out a
secondary headache disorder but to provide adequate
headache treatment; but the latter goal is not always ac-
complished. In our study, headache had not disappeared
at the time of ED discharge in 62.7% of the 244 patients.
This rate, dramatic in itself, was still lower than that of
another study in the French department, where migraine
had not disappeared at the time of discharge from ED in
80.2% of patients [8]. There are significant variations in
headache management between and within EDs due to
lack of strong recommendations, physician comfort and
familiarity with specific medications, belief in efficacy,
concern about short-term side effects, and patient demand
[37–39]. Only recently, the Canadian Headache Society
and the American Headache Society have provided
evidence-based therapeutic recommendations for mi-
graine requiring treatment in emergency settings [40, 41].
The fifth and final step in the management of head-
aches in ED is discharge. Significant evidence suggests
that migraine discharge management is often subopti-
mal. About 40% of emergency physicians never pre-
scribed triptans on discharge [42], about 60% of patients
had no documented discharge medications and 2/3 of
patients did not receive a medical follow-up recommen-
dation [18]. These malpractices contribute to the high
rate of ED return visits noted among migraine patients
[43]. Another study found a high percentage of patients
(34.7%) discharged without a prescription and again the
most commonly prescribed drugs were analgesics and
NSAIDs rather than migraine-specific drugs [8]. Our
data, in line with the previous literature, showed that
43.9% of patients were discharged without a prescrip-
tion, while the most commonly prescribed drugs for the
treatment of headache were NSAIDs (33.2%) and para-
cetamol (11.1%), while triptans were prescribed only to
1.6% (Table 5).
Considering what has been discussed earlier on the
journey through ED of a patient complaining of head-
ache, a fast track between ED and a headache clinic is a
step forward in headache management. Headache is the
most common disorder among patients presenting to
ED with neurological complaints [44] and although in
most cases it is discharged as a non-urgent disorder,
these patients feel they need urgent medical evaluation
[45]. On the contrary, migraine patients, especially those
with a known diagnosis, should have the idea that their
headache is not a life-threatening condition and if they
get to ED it is more because of access problems and less
because of a perceived need for emerging treatment. In-
appropriate use of ED leads to overcrowding and conse-
quently an increase in intervention times, which is one
of the main reasons for leaving ED prematurely [46], es-
pecially among patients with a compliant of headache
[47]. This suggests that a healthcare system could reduce
ED visits among migraineurs by increasing the availabil-
ity of urgent care or walk-in appointments [48].
Further evidence of the importance of rapid referral to
a headache centre comes from an analysis of ED use by
migraine patients. The AMPP study showed that only a
small subset of respondents used ED for the treatment
of severe headaches in the previous 12 months: 3% vis-
ited the ED once and another 3% visited ED more than
once [36]. Interestingly, in a previous study, we showed
that among the 548 migraine patients who attended our
headache clinic and were undergoing continuous treat-
ment and regular follow-up visits, only 0.9% of them
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entered the ED during the entire 2-years observation
period [49]. This is explained by the fact that migraine
prevention and prescription of migraine-specific rescue
therapies reduce the use of resources in general, and ED
visits in particular [50–52]. In addition to improving the
health and quality of life of patients, a preferential route
between ED and the headache clinic can lead to signifi-
cant cost savings, considering that ED care is consider-
ably more expensive than both hospital outpatient care
and office-based outpatient care. At a time of economic
hardship and availability of new and expensive treat-
ments, such as monoclonal antibodies targeting the cal-
citonin gene-related peptide, a virtuous allocation of
economic resources becomes mandatory [53].
Limitations
The study has several potential limitations. First, there
are inherent limitations related to the use of the data
collected primarely for clinical care, such as errors in re-
cording some information that could be perceived as
secondary importance in the particular setting of ED.
However, we believe that the variables of primary inter-
est in this analysis, including socio-demographic charac-
teristics, diagnostic procedures, specialist consultations
and drugs should not have been subject to inaccurate re-
cording. Secondly, the enrollment period was between
January 1, 2015 and December 31, 2018 and, for this
reason, most patients were diagnosed according to the
beta version of the ICHD-III published in 2013, while
the definitive version was published in early 2018.
Thirdly, the decision of ED physicians whether or not to
refer a patient discharged from the ED for a severe head-
ache to our headache centre is totally personal and inde-
pendent. As a result, there is a possibility that patients
may have been referred mainly by some physicians and
not by others and that this may introduce a selection
bias towards one type of patient rather than another. Fi-
nally, this study was conducted in a single university
hospital for tertiary care and our results may not be gen-
eralized to other countries or even to other Italian re-
gions or to other EDs that may have different
organizational and therapeutic protocols.
Conclusions
The vast majority of patients who went to the emer-
gency room complaining of a headache received the
same treatment regardless of the cause of the headache
and for this reason in many cases the headache had not
yet resolved at the time of discharge. We have shown a
high rate of misdiagnosis of primary headaches and a
short route between ED and the headache center is of
primary importance to help the patient achieve a defini-
tive diagnosis and appropriate treatment. Reducing the
number of emergency visits for primary headaches, and
in particular migraine headaches, is the goal and easy
and rapid referral to headache specialists can prevent
further recourse to ED. In addition, an implementation
of referral from ED to the headache center of the same
hospital, if present, can increase the quality of patient
management and, by sharing information about hospi-
tal’s EMRs, can avoid the need to repeat diagnostic in-
vestigations and reduce time and expense, thus leading
to a better allocation of public resources.
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